175 related articles for article (PubMed ID: 11907716)
1. Biological variability in serum and urinary indices of bone formation and resorption in dogs.
Ladlow JF; Hoffmann WE; Breur GJ; Richardson DC; Allen MJ
Calcif Tissue Int; 2002 Mar; 70(3):186-93. PubMed ID: 11907716
[TBL] [Abstract][Full Text] [Related]
2. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
[TBL] [Abstract][Full Text] [Related]
4. Serum markers of bone metabolism in dogs.
Allen MJ; Hoffmann WE; Richardson DC; Breur GJ
Am J Vet Res; 1998 Mar; 59(3):250-4. PubMed ID: 9522938
[TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
6. Urinary markers of type I collagen degradation in the dog.
Allen MJ; Allen LC; Hoffmann WE; Richardson DC; Breur GJ
Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
8. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
Abildgaard N; Brixen K; Eriksen EF; Kristensen JE; Nielsen JL; Heickendorff L
Haematologica; 2004 May; 89(5):567-77. PubMed ID: 15136220
[TBL] [Abstract][Full Text] [Related]
9. Evidence for increased bone formation following a brief endurance-type training intervention in adolescent males.
Eliakim A; Raisz LG; Brasel JA; Cooper DM
J Bone Miner Res; 1997 Oct; 12(10):1708-13. PubMed ID: 9333132
[TBL] [Abstract][Full Text] [Related]
10. Bone marker alterations in patients with type 1 Gaucher disease.
Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
Ostrowska Z; Kos-Kudla B; Swietochowska E; Marek B; Kajdaniuk D; Górski J
Neuro Endocrinol Lett; 2001 Apr; 22(2):129-36. PubMed ID: 11335889
[TBL] [Abstract][Full Text] [Related]
13. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline/creatinine (DPD) and serum ICTP, and an evaluation of the DPD/osteocalcin and ICTP/osteocalcin ratios.
Carlson K; Larsson A; Simonsson B; Turesson I; Westin J; Ljunghall S
Eur J Haematol; 1999 May; 62(5):300-6. PubMed ID: 10359057
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bone resorption markers during hypocalcemia in dairy cows.
Liesegang A; Sassi ML; Risteli J; Eicher R; Wanner M; Riond JL
J Dairy Sci; 1998 Oct; 81(10):2614-22. PubMed ID: 9812267
[TBL] [Abstract][Full Text] [Related]
16. The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.
Generali D; Berruti A; Tampellini M; Dovio A; Tedoldi S; Bonardi S; Tucci M; Allevi G; Aguggini S; Milani M; Bottini A; Dogliotti L; Angeli A
Bone; 2007 Jan; 40(1):182-8. PubMed ID: 16935041
[TBL] [Abstract][Full Text] [Related]
17. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of the bone markers osteocalcin and the carboxyterminal cross-linked telopeptide of type-I collagen in evaluating osteogenesis in a canine crural lengthening model.
Theyse LF; Mol JA; Voorhout G; Terlou M; Hazewinkel HA
Vet J; 2006 May; 171(3):525-31. PubMed ID: 16624720
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
Takahashi S
Clin Calcium; 2006 Apr; 16(4):581- 90. PubMed ID: 16582508
[TBL] [Abstract][Full Text] [Related]
20. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
St Clair EW; Moak SA; Wilkinson WE; Sanders L; Lang T; Greenwald RA
J Rheumatol; 1998 Aug; 25(8):1472-9. PubMed ID: 9712086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]